In addition, Perry et al. reported that the elevated plasma and fecal levels of microbiota-derived acetate can disrupt glucose/insulin homeostasis, and thus, contribute to metabolic disorder by mediating the gut-brain axis [49]. Here, INS is linked to metabolic disease.